"Aldehyde Oxidoreductases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Oxidoreductases that are specific for ALDEHYDES.
| Descriptor ID |
D000445
|
| MeSH Number(s) |
D08.811.682.657.163
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aldehyde Oxidoreductases".
Below are MeSH descriptors whose meaning is more specific than "Aldehyde Oxidoreductases".
This graph shows the total number of publications written about "Aldehyde Oxidoreductases" by people in this website by year, and whether "Aldehyde Oxidoreductases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aldehyde Oxidoreductases" by people in Profiles.
-
Reverse Phase Protein Array Reveals Correlation of Retinoic Acid Metabolism With Cardiomyopathy in Friedreich's Ataxia. Mol Cell Proteomics. 2021; 20:100094.
-
Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene. Adv Protein Chem Struct Biol. 2020; 120:349-377.
-
Sequence variants in nine different genes underlying rare skin disorders in 10 consanguineous families. Int J Dermatol. 2017 Dec; 56(12):1406-1413.
-
Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam. Int J Cancer. 2017 Jan 15; 140(2):460-468.
-
Lipid metabolism in Rhodnius prolixus: Lessons from the genome. Gene. 2017 Jan 05; 596:27-44.
-
FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells. Cancer Res. 2016 12 15; 76(24):7219-7230.
-
Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action. J Cardiovasc Pharmacol Ther. 2016 09; 21(5):478-85.
-
Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs. J Am Heart Assoc. 2015 Jan 26; 4(1):e001521.
-
Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes. Acta Neuropathol Commun. 2014 Dec 20; 2:160.
-
Importance of ALDH1A enzymes in determining human testicular retinoic acid concentrations. J Lipid Res. 2015 Feb; 56(2):342-57.